Bioinformatics analysis deciphering the transcriptomic signatures associated with signalling pathways and prognosis in the myelodysplastic syndromes

References

• Corey SJ, Minden MD, Barber DL, et al. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer. 2007;7:118–129.
   PubMed Web of Science ®Google Scholar
• Montalban-Bravo G, Garcia-Manero G. Myelodysplastic Syndromes: 2018 Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management. Am J Hematol; 93:129–147.
   PubMed Web of Science ®Google Scholar
• Maciejewski JP, Balasubramanian SK. Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic Age. Hematology. 2017;2017:66–72.
   PubMedGoogle Scholar
• Gerstung M, Pellagatti A, Malcovati L, et al. Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes. Nat Commun. 2015;6:5901.
   PubMed Web of Science ®Google Scholar
• Le Y. Screening and identification of Key candidate genes and pathways in myelodysplastic syndrome by bioinformatic analysis. PeerJ. 2019;7:e8162.
   PubMed Web of Science ®Google Scholar
• Ogawa S. Genetics of MDS. Genetics of MDS; 133:1049–e1059.
   Google Scholar
• Wang M-J, Liu W-Y, Wang X-Y, et al. Autophagy gene panel-based prognostic model in myelodysplastic syndrome. Front Oncol. 2021;10.
   Web of Science ®Google Scholar
• Hu F, Chen S, Dai Y, et al. Identification of a metabolic gene panel to predict the prognosis of myelodysplastic syndrome. J Cell Mol Med. 2020;24:6373–6384.
   PubMed Web of Science ®Google Scholar
• Pellagatti A, Cazzola M, Giagounidis AAN, et al. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. Blood. 2006;108:337–345.
   PubMed Web of Science ®Google Scholar
• Pellagatti A, Cazzola M, Giagounidis A, et al. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia. 2010;24:756–764.
   PubMed Web of Science ®Google Scholar
• Graubert TA, Shen D, Ding L, et al. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet. 2012;44:53–57.
   Web of Science ®Google Scholar
• Pellagatti A, Armstrong RN, Steeples V, et al. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations. Blood. 2018;132:1225–1240.
   PubMed Web of Science ®Google Scholar
• Xia J, Gill EE, Hancock REW. NetworkAnalyst for Statistical, Networkanalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat Protoc. 2015;10:823–844.
   PubMed Web of Science ®Google Scholar
• Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118–127.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47–e47.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene Set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–15550.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Furumichi M, Tanabe M, et al. Temporal self-regulation of transposition through host-independent transposase rodlet formation. Nucleic Acids Res. 2017;45:353–366.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Methodological)). 1995;57:289–300.
   Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. H3.3K4M destabilizes enhancer H3K4 methyltransferases MLL3/MLL4 and impairs adipose tissue development. Nucleic Acids Res. 2019;47:607–620.
   PubMed Web of Science ®Google Scholar
• Chin C-H, Chen S-H, Wu H-H, et al. Cytohubba: identifying Hub objects and Sub-networks from complex interactome. BMC Syst Biol. 2014;8:S11.
   PubMed Web of Science ®Google Scholar
• Bader GD, Hogue CWV. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2.
   PubMed Web of Science ®Google Scholar
• Robin X, Turck N, Hainard A, et al. Proc: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
   PubMed Web of Science ®Google Scholar
• Yang Q, Wang R, Wei B, et al. Candidate biomarkers and molecular mechanism investigation for glioblastoma multiforme utilizing WGCNA. Biomed Res Int. 2018;2018:e4246703.
   PubMed Web of Science ®Google Scholar
• Clark NR, Hu KS, Feldmann AS, et al. The characteristic direction: A geometrical approach to identify differentially expressed genes. BMC Bioinformatics. 2014;15:79.
   PubMed Web of Science ®Google Scholar
• Wang J, Clay-Gilmour AI, Karaesmen E, et al. Genome-Wide association analyses identify variants in IRF4 associated With acute myeloid leukemia and myelodysplastic syndrome susceptibility. Front Genet. 2021;12:554948.
   PubMed Web of Science ®Google Scholar
• Flotho C, Paulun A, Batz C, et al. Akap12, a gene with tumour suppressor properties, Is a target of promoter DNA methylation in childhood myeloid malignancies. Br J Haematol. 2007;138:644–650.
   PubMed Web of Science ®Google Scholar
• Pellagatti A, Cazzola M, Giagounidis A, et al. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia. 2010;24:756–764.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhao L, Wei X, et al. Integrated bioinformatic analysis of microarray data reveals shared gene signature between MDS and AML. Oncol Lett. 2018;16:5147–5159.
   PubMed Web of Science ®Google Scholar
• Ryan DP, Matthews JM. Protein-Protein interactions in human disease. Curr Opin Struct Biol. 2005;15:441–446.
   PubMed Web of Science ®Google Scholar
• Yoyen-Ermis D, Tunali G, Tavukcuoglu E, et al. Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS. Sci Rep. 2019;9:11697.
   PubMed Web of Science ®Google Scholar
• Saunthararajah Y, Sekeres M, Advani A, et al. Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes. J Clin Invest. 2015;125:1043–11055.
   PubMed Web of Science ®Google Scholar
• Hemmati S, Haque T, Gritsman K. Inflammatory signaling pathways in preleukemic and leukemic stem cells. Front Oncol. 2017;7:265.
   PubMed Web of Science ®Google Scholar
• Shao X, Miao M, Qi X, et al. Ras-Proximate-1 GTPase-activating protein and Rac2 May play pivotal roles in the initial development of myelodysplastic syndrome. Oncol Lett. 2012;4:289–298.
   PubMed Web of Science ®Google Scholar
• Zhou T, Perez SN, Cheng Z, et al. Context matters: distinct disease outcomes as a result of crebbp hemizygosity in different mouse bone marrow compartments. PLOS ONE. 2016;11:e0158649.
   PubMed Web of Science ®Google Scholar
• Spoo AC, Lübbert M, Wierda WG, et al. Cxcr4 Is a prognostic marker in acute myelogenous leukemia. Blood. 2007;109:786–791.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wu L. Identification of latent core genes and pathways associated with myelodysplastic syndromes based on integrated bioinformatics analysis. Hematology. 2020;25:299–308.
   PubMed Web of Science ®Google Scholar
• Sun PG, Gao L, Han S. Prediction of human disease-related gene clusters by clustering analysis. Int J Biol Sci. 2011;7:61–73.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xiong H, Duan J, et al. High Expression of PXN Predicts a Poor Prognosis in Acute Myeloid Leukemia 2021.
   Google Scholar
• ElBaiomy MA, Aref S, El Zaafarany M, et al. Prognostic Impact of Lymphoid Enhancer Factor 1 Expression and Serum Galectin.3 in Egyptian AML Patients. Adv Hematol. 2019;2019:2352919), doi:10.1155/2019/2352919.
   PubMedGoogle Scholar
• Tisone JA, Bohman JE, Theil KS, et al. Aberrant expression of CD19 as a marker of monocytic lineage in acute myelogenous leukemia. Am J Clin Pathol. 1997;107:283–291.
   PubMed Web of Science ®Google Scholar
• Desouki MM, Post GR, Cherry D, et al. PAX-5: A valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms. Clin Med Res. 2010;8:84–88.
   PubMedGoogle Scholar
• Pellagatti A, Marafioti T, Paterson JC, et al. Marked downregulation of the granulopoiesis regulatorLEF1is associated with disease progression in the myelodysplastic syndromes. Br J Haematol. 2009;146:86–90.
   PubMed Web of Science ®Google Scholar